Lawrie Charles H
Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Br J Haematol. 2007 Jun;137(6):503-12. doi: 10.1111/j.1365-2141.2007.06611.x.
MicroRNAs are a recently discovered class of small ( approximately 22nt) endogenously expressed translational-repressor RNAs that play key roles in many cellular pathways and whose aberrant expression appears to be a common feature of malignancy. MicroRNAs are expressed in specific haematological cell types and play important regulatory roles in early haematopoietic differentiation, erythropoiesis, granulocytosis, megakaryocytosis and lymphoid development. Additionally, there is an emerging body of research to suggest that microRNAs play an important role in the pathology of haematological malignancies. MicroRNAs have been found to act as both tumour suppressor molecules [e.g. MIRN15A (miR-15a), MIRN16-1 (miR-16-1)] in leukaemias and have oncogenic properties [e.g. MIRN155 (miR-155) and MIRN17-92 (miR-17-miR-92) cluster] in lymphomas. This review discusses the rapidly accumulating research that points to the major role microRNAs play in both haematopoiesis and haematological malignancy.
微小RNA是最近发现的一类小(约22个核苷酸)内源性表达的翻译抑制性RNA,在许多细胞途径中起关键作用,其异常表达似乎是恶性肿瘤的一个共同特征。微小RNA在特定的血液细胞类型中表达,并在早期造血分化、红细胞生成、粒细胞生成、巨核细胞生成和淋巴细胞发育中发挥重要调节作用。此外,越来越多的研究表明微小RNA在血液系统恶性肿瘤的病理学中起重要作用。在白血病中,微小RNA已被发现可作为肿瘤抑制分子[如MIRN15A(miR-15a)、MIRN16-1(miR-16-1)],而在淋巴瘤中具有致癌特性[如MIRN155(miR-155)和MIRN17-92(miR-17-miR-92)簇]。本综述讨论了迅速积累的研究,这些研究表明微小RNA在造血和血液系统恶性肿瘤中都起着主要作用。